社区2型糖尿病患者空腹血糖波动轨迹及其影响因素分析

许月瑶; 焦惠艳; 聂朦; 袁志权; 邬娜; 李成英; 吴龙; 伍永红; 钟理; 李亚斐; 杨敬源

doi:10.16016/j.2097-0927.202209169

您当前的位置：

首页 >

文章列表页 >

社区2型糖尿病患者空腹血糖波动轨迹及其影响因素分析

公共卫生与预防医学 | 更新时间：2026-01-09

- 社区2型糖尿病患者空腹血糖波动轨迹及其影响因素分析
- Trajectory and influencing factors of fasting blood glucose fluctuations in patients with type 2 diabetes mellitus in community
- 陆军军医大学学报 2023年45卷第8期页码：786-793
- 作者机构：
  
  1.550025 贵阳，贵州医科大学公共卫生与健康学院流行病与卫生统计学系环境污染与疾病监控教育部重点实验室
  2.400038 重庆，陆军军医大学(第三军医大学)军事预防医学系军队流行病学教研室
  3.400032 重庆，沙坪坝区双碑社区卫生服务中心
  4.401120 重庆，重庆医科大学附属第三医院心血管疾病中心
- 作者简介：
  
  [杨敬源，E-mail：yangjingyuan@gmc.edu.cnYANG Jingyuan, E-mail: yangjingyuan@gmc.edu.cn
- 基金信息：
- DOI：10.16016/j.2097-0927.202209169
  中图分类号： R195.4;R446.122;R587.1
- 收稿：2022-09-19，
  
  修回：2022-11-16，
  
  纸质出版：2023-04-30
- 稿件说明：
移动端阅览
许月瑶, 焦惠艳, 聂朦, 等. 社区2型糖尿病患者空腹血糖波动轨迹及其影响因素分析[J]. 陆军军医大学学报, 2023,45(8):786-793.

Yueyao XU, Huiyan JIAO, Meng NIE, et al. Trajectory and influencing factors of fasting blood glucose fluctuations in patients with type 2 diabetes mellitus in community[J]. Journal of Army Medical University, 2023, 45(8): 786-793.
许月瑶, 焦惠艳, 聂朦, 等. 社区2型糖尿病患者空腹血糖波动轨迹及其影响因素分析[J]. 陆军军医大学学报, 2023,45(8):786-793. DOI： 10.16016/j.2097-0927.202209169.

Yueyao XU, Huiyan JIAO, Meng NIE, et al. Trajectory and influencing factors of fasting blood glucose fluctuations in patients with type 2 diabetes mellitus in community[J]. Journal of Army Medical University, 2023, 45(8): 786-793. DOI： 10.16016/j.2097-0927.202209169.

摘要

目的

构建社区2型糖尿病患者的空腹血糖波动的轨迹模型，并分析不同类别血糖波动轨迹的影响因素。

方法

本研究采用回顾性队列研究，纳入769例于2012年1月至2019年12月在重庆市沙坪坝区双碑社区卫生服务中心建立居民健康档案并加入社区随访管理的2型糖尿病患者，基于群体的轨迹模型(group-based trajectory modelling，GBTM)来识别、构建糖尿病患者的空腹血糖波动轨迹，利用贝叶斯信息准则(Bayesian information criterion，BIC)、平均验后分组概率(average posterior probability，AvePP)等评价指标选择最佳亚组数的轨迹，比较不同类别轨迹在人口学特征、个人健康状况、疾病史、生活方式、服药依从性等方面的差异，运用无序多分类Logistic回归模型分析不同波动轨迹的影响因素。

结果

运用GBTM分析，将社区769名2型糖尿病患者分为3个不同波动轨迹亚组，分别为“低水平平稳组”、“高水平下降组”和“中水平上升组”。以低水平平稳组为对照，无序多分类Logistic回归分析结果显示：有高血压病史、未服药患者被归为“高水平下降组”的可能性较低，即这些患者的血糖从高水平逐渐下降的可能性较低(

=0.50，95%

：0.28~0.90，

=0.021；

=0.13，95%

：0.03~0.56，

=0.006)。但是偶尔或不锻炼、饮酒或已戒酒的患者更倾向于被归为“高水平下降组”(

=2.02，95%

：1.15~3.55，

=0.014；

=2.32，95%

：1.16~4.63，

=0.017)。与规律服药的糖尿病患者相比，间断服药的糖尿病患者更倾向于被归为“中水平上升组” (

=6.02，95%

：2.86~12.66，

0.001)。

结论

社区2型糖尿病患者空腹血糖轨迹呈现不同的动态变化特征；高血压史、服药依从性、锻炼频率和饮酒可能影响患者出现不同血糖波动轨迹。

Abstract

Objective

To construct trajectory models of fasting blood glucose fluctuations in type 2 diabetes mellitus (T2DM) patients in community

and analyze the influencing factors of the trajectory of glucose fluctuation in different categories.

Methods

A retrospective cohort study was carried out on 769 T2DM patients who had health records and been involved in the diabetic management in Shuangbei Community Health Service Center of Shapingba District

Chongqing from 2012 to 2019. Group-based trajectory modelling (GBTM) was employed to identify and construct the fluctuation trajectory of fasting blood glucose in the patients. BIC

AvePP and other evaluation indicators were used to select the optimum subgroup number model. Then the differences in demographic characteristics

health status

medical history

lifestyle

medication compliance

etc

were compared among different categories. Multinomial logistic regression model was constructed to explore the influencing fac

tors of different fluctuation trajectories.

Results

The 769 T2DM subjects were divided into 3 groups of different fluctuation trajectories by GBTM

that is

low-level steady

high-level falling

and medium-level rising groups. Multinomial logistic regression analysis indicated that the patients with a history of hypertension and not taking medication were less likely to be assigned into the high-level falling group than into the low-level steady group

indicating that their high glucose level was not predisposed to a progressive decline (

=0.50

95%

: 0.28~0.90

=0.021;

=0.13

95%

: 0.03~0.56

=0.006). However

the subjects who occasionally or not exercised

consumed alcohol or abstained from alcohol were more likely to be assigned into the high-level falling group (

=2.02

95%

: 1.15~3.55

=0.014;

=2.32

95%

: 1.16~4.63

=0.017). When compared with the patients with regular medication

those with intermittent medication were more likely to be assigned into the medium-level rising group (

=6.02

95%

: 2.86~12.66

0.001).

Conclusion

There are different trajectories of dynamic changes in fasting glucose for T2DM patients. History of hypertension

medication adherence

frequency of exercise

and alcohol consumption may be associated with different trajectories of blood glucose fluctuations.

关键词

Keywords

references

ZHENG Y, LEY S H, HU F B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol, 2018, 14(2): 88-98. DOI: 10.1038/nrendo.2017.151.

中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 国际内分泌代谢杂志, 2021, 41(5): 482-548. DOI: 10.3760/cma.j.cn121383-20210825-08063.

Chinese Diabetes Society of Chinese Medical Association. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Int J Endocrinol Metab, 2021, 41(5): 482-548. DOI: 10.3760/cma.j.cn121383-20210825-08063.

RODBARD D. Glucose variability: a review of clinical applications and research developments[J]. Diabetes Technol Ther, 2018, 20(S2): S25-S215. DOI: 10.1089/dia.2018.0092.

YOON J E, SUNWOO J S, KIM J S, et al . Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients[J ] . J Diabetes Complications, 2017, 31(2): 390-394. DOI: 10.1016/j.jdiacomp.2016.11.014.

CARODSO C L, LEITE N C, MORAM C M, et al . Long-term visit-to-visit glycemic variability as predictor of micro-and macrovascular complications in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study[J ] . Cardiovasc Diabetol, 2018, 17(1): 33. DOI: 10.1186/s12933-018-0677-0.

ZHOU Z, SUN B, HUANG S Q, et al . Glycemic variability: adverse clinical outcomes and how to improve it?[J ] . Cardio-vasc Diabetol, 2020, 19(1): 102. DOI: 10.1186/s12933-020-01085-6.

MARTINEZ M, SANTAMARINA J, PAVESI A, et al . Glycemic variability and cardiovascular disease in patients with type 2 diabetes[J ] . BMJ Open Diabetes Res Care, 2021, 9(1): e002032. DOI: 10.1136/bmjdrc-2020-002032.

倪佳英, 马晓静, 周健. 血糖波动异常与糖尿病并发症的研究进展[J]. 中华糖尿病杂志, 2022, 14(04): 388-392. DOI: 10.3760/cma.j.cn115791-20210510-00262.

NI J Y, MA X J, ZHOU J. Research progress of abnormal glycemic variability and diabetic complications[J]. Chin J Diabetes Mellit, 2022, 14(4): 388-392. DOI: 10.3760/cma.j.cn115791-20210510-00262.

NAGIN D S, ODGERS C L. Group-based trajectory modeling in clinical research[J]. Annu Rev Clin Psychol, 2010, 6: 109-138. DOI: 10.1146/annurev.clinpsy.121208.131413.

张晨旭, 谢峰, 林振, 等. 基于组轨迹模型及其研究进展[J]. 中国卫生统计, 2020, 37(6): 946-949. DOI: 10.3969/j.issn.1002-3674.2020.06.039.

ZHANG C X, XIE F, LIN Z, et al . Group trajectory model and its research progress[J ] . Chin J Health Stat, 2020, 37(6): 946-949. DOI: 10.3969/j.issn.1002-3674.2020.06.039.

冯国双, 于石成, 刘世炜. 轨迹分析模型在追踪数据分析中的应用[J]. 中国预防医学杂志, 2014, 15(3): 292-295. DOI: 10.16506/j.1009-6639.2014.03.009.

FENG G S, YU S C, LIU S W. Application of trajectory analysis model in tracking data analysis[J]. Chin Prev Med, 2014, 15(3): 292-295. DOI: 10.16506/j.1009-6639.2014.03.009.

Lennon H, Kelly S, Sperrin M, et al . Framework to construct and interpret latent class trajectory modelling[J ] . BMJ Open, 2018, 8(7): e020683. DOI: 10.1136/bmjopen-2017-020683.

LEE D Y, HAN K, PARK S, et al . Glucose variability and the risks of stroke, myocardial infarction, and all-cause mortality in individuals with diabetes: retrospective cohort study[J ] . Cardiovasc Diabetol, 2020, 19(1): 144. DOI: 10.1186/s12933-020-01134-0.

SHEN Y, ZHOU J, SHI L Z, et al . Association between visit-to-visit HbA1c variability and the risk of cardiovascular disease in patients with type 2 diabetes[J ] . Diabetes Obes Metab, 2021, 23(1): 125-135. DOI: 10.1111/dom.14201.

QU Y M, JACOBER S J, ZHANG Q Y, et al . Rate of hypo-glycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data[J ] . Diabetes Technol Ther, 2012, 14(11): 1008-1012. DOI: 10.1089/dia.2012.0099.

PENCKOFER S, QUINN L, BYRN M, et al . Does glycemic variability impact mood and quality of life?[J ] . Diabetes Technol Ther, 2012, 14(4): 303-310. DOI: 10.1089/dia.2011.0191.

HIRAKAWA Y, ARIMA H, ZOUNGAS S, et al . Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial[J ] . Diabetes Care, 2014, 37(8): 2359-2365. DOI: 10.2337/dc14-0199.

KAZE A D, SANTHANAM P, ERQOU S, et al . Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study[J ] . BMJ Open Diabetes Res Care, 2020, 8(2): e001753. DOI: 10.1136/bmjdrc-2020-001753.

娄海飞, 张丽华, 赵月, 等. 糖尿病足病伴高血压患者血糖控制的影响因素[J]. 中华高血压杂志, 2022, 30(3): 287-289. DOI: 10.16439/j.issn.1673-7245.2022.03.015.

LOU H F, ZHANG L H, ZHAO Y, et al . Influencing factors of blood glucose control in patients with diabetic foot disease and hypertension[J ] . Chin J Hypertens, 2022, 30(3): 287-289. DOI: 10.16439/j.issn.1673-7245.2022.03.015.

PERREAULT L, PAN Q, ARODA V R, et al . Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS)[J ] . Diabet Med, 2017, 34(12): 1747-1755. DOI: 10.1111/dme.13453.

WEI G S, COADY S A, GOFF D C, Jr, et al . Blood pressure and the risk of developing diabetes in African Americans and whites: ARIC, CARDIA, and the Framingham heart study[J ] . Diabetes Care, 2011, 34(4): 873-879. DOI: 10.2337/dc10-1786.

中华医学会糖尿病学分会, 国家基层糖尿病防治管理办公室. 国家基层糖尿病防治管理手册(2022)[J]. 中华内科杂志, 2022, 61(7): 717-748. DOI: 10.3760/cma.j.cn112138-20220509-00350.

Chinese Diabetes Society of Chinese Medical Associntion, National Office for Primary Diabetes Care. National handbook for the prevention and control of diabetes in prim ary care (2022)[J]. Chin J Intern Med, 2022, 61(7): 717-748. DOI: 10.3760/cma.j.cn112138-20220509-00350.

COLBERG S R, SIGAL R J, YARDLEY J E, et al . Physical activity/exercise and diabetes: a position statement of the American diabetes association[J ] . Diabetes Care, 2016, 39(11): 2065-2079. DOI: 10.2337/dc16-1728.

LUMB A. Diabetes and exercise[J]. Clin Med (Lond), 2014, 14(6): 673-676. DOI: 10.7861/clinmedicine.14-6-673.

MELMER A, KEMPF P, LAIMER M. The role of physical exercise in obesity and diabetes[J]. Praxis (Bern 1994), 2018, 107(17/18): 971-976. DOI: 10.1024/1661-8157/a003065.

FRANCESCONI C, NIEBAUER J, HABERP, et al . Life-style: physical activity and training as prevetion and therapy of type 2 diabetes mellitus (Update 2019)[J ] . Wien Klin Wochenschr, 2019, 131(Suppl 1): 61-66. DOI: 10.1007/s00508-019-1457-x.

KNOWLER W C, BARRETT-CONNOR E, FOWLER S E, et al . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin[J ] . N Engl J Med, 2002, 346(6): 393-403. DOI: 10.1056/NEJMoa012512.

LIN A H, ZHANG G R, LIU Z T, et al . Community-based lifestyle intervention for reducing blood pressure and glucose among middle-aged and older adults in China: a pilot study[J ] . Int J Environ Res Public Health, 2014, 11(11): 11645-11663. DOI: 10.3390/ijerph111111645.

ZHANG Y, PAN X F, CHEN J, et al . Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies[J ] . Diabetologia, 2020, 63(1): 21-33. DOI: 10.1007/s00125-019-04985-9.

KOHNERT K D, AUGSTEIN P, ZANDER E, et al . Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents[J ] . Diabetes Care, 2009, 32(6): 1058-1062. DOI: 10.2337/dc08-1956.

PAGKALOS E M. Combinations of insulin and oral hypoglycemic agents in diabetes mellitus type 2[J]. Diabetes Res Clin Pract, 2011, 93: S100-S101. DOI: 10.1016/S0168-8227(11)70022-5.

KOUFAKIS T, MUSTAFA O G, ZEBEKAKIS P, et al . Oral antidiabetes agents for the management of inpatient hyper-glycaemia: so far, yet so close[J ] . Diabet Med, 2020, 37(9): 1418-1426. DOI: 10.1111/dme.14329.

CAPOCCIA K, ODEGARD P S, LETASSY N. Medication adherence with diabetes medication[J]. Diabetes Educ, 2016, 42(1): 34-71. DOI: 10.1177/0145721715619038.

赵茜, 郭雅丽, 许琪, 等. 格列齐特药物治疗下2型糖尿病患者血糖控制水平影响因素研究[J]. 中国慢性病预防与控制, 2012, 20(3): 314-316. DOI: 10.16386/j.cjpccd.issn.1004-6194.2012.03.035.

ZHAO Q, GUO Y L, XU Q, et al . The influential factors of fasting blood glucose in patients of type 2 diabetes mellitus with gliclazide treatment[J ] . Chin J Prev Control Chronic Dis, 2012, 20(3): 314-316. DOI: 10.16386/j.cjpccd.issn.1004-6194.2012.03.035.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

2型糖尿病患者下肢血管病变介入治疗远期再狭窄及影响因素分析

社区高血压患者收缩压波动轨迹及其影响因素的研究

直肠癌术后回肠造口还纳患者发生低位前切除综合征的影响因素分析

肾移植受者运动恐惧潜在剖面分析及影响因素研究